<DOC>
	<DOCNO>NCT00999466</DOCNO>
	<brief_summary>AZD8848 new drug test treatment asthma allergic rhinitis ( hayfever ) . This study two part include 59 asthmatic patient total . The first part investigate tolerability safety AZD8848 second part investigate therapeutic effect AZD8848 well patient tolerate drug .</brief_summary>
	<brief_title>The Tolerability Effects AZD8848 Allergic Asthma Subjects Challenged With Inhaled Allergen</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<criteria>FEV1 &gt; 70 % predict normal prebronchodilator Documented history asthma Presence allergic sensitivity Clinically relevant disease and/or abnormality ( past present ) , , opinion Investigator , may either put patient risk participation study , influence result study , patient 's ability participate study . Symptomatic allergic rhinitis Any clinical relevant abnormal finding physical examination assessment may put patient risk participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>